+499.5%
MRNA vs LDOS
-24.0%
+523.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.5% | -2.8% | -2.5% |
| 7D | +5.5% | -5.4% | +10.9% | +9.0% |
| 30D | +158.7% | +4.9% | +153.8% | +164.7% |
| 3M | +182.1% | +7.2% | +174.9% | +184.8% |
| 6M | +151.8% | -24.2% | +176.1% | +195.9% |
| YTD | +393.6% | -25.8% | +419.4% | +472.8% |
| 1Y | +499.5% | -24.7% | +524.2% | +521.2% |
| All | +499.5% | -24.0% | +523.5% | +521.2% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling